Hillman 2008 [] Tablets: 1,600 IU placebo 6 months 15 Children and 7 - 13 years. Serum minerals, bone D3+500 mg calcium adolescents. turnover, BMC carbonate 2/d. Gontijo-Amaral 300 mg oral placebo 8 weeks 44 Stable clinical Range: 7 - 19 years. Respiratory muscle 2008 [] (5-12 condition. strength, AE Drury 2008 [] 5 mg/day of vitamin 1 mg/day of vitamin 1 month 14 Pancreatic Range: 8 - 18 years. Vitamin K status K1. K1. insufficient. Watson 2008 [] Behavioral standard care 10 weeks 74 Understand written >16 Weight change, Nutrition Education English. nutrition knowledge (topics: increasing score, self-efficacy intake, managing score, fat intake, appetite, etc). health-related quality-of-life score Schnabel 2007 [] 0.070 mg/kg or 0.039 placebo 48 weeks, followed by 63 Bone age of 8-18 Range: 9 - 20 years. Change in FEV1, mg/kg body weight an open treatment years, BMI 10th height, weight, Somatropin. Max period of 24 weeks. and/or weight 3rd exercise tolerance. daily dosage: 3.4 mg. percentile despite high caloric intake. Hardin 2005 [] 1 year of GH (0.3 no GH for 1 year, 24 months 18 Received EN Range: 9 - 13 years. Pulmonary function, mg/kg per week) followed by 1 year of supplementation anthropometrics, followed by a second GH for≥2 years hospitalizations, year (injection) before enrollment. antibiotics, intake, protein turnover.
Hillman 2008 [] Tablets: 1,600 IU D3+500 mg calcium carbonate 2/d. placebo 6 months 15 Children and adolescents. 7 - 13 years. Serum minerals, bone turnover, BMC Gontijo-Amaral 2008 [] 300 mg oral (5-12 placebo 8 weeks 44 Stable clinical condition. Range: 7 - 19 years. Respiratory muscle strength, AE Drury 2008 [] 5 mg/day of vitamin K1. 1 mg/day of vitamin K1. 1 month 14 Pancreatic insufficient. Range: 8 - 18 years. Vitamin K status Watson 2008 [] Behavioral Nutrition Education (topics: increasing intake, managing appetite, etc). standard care 10 weeks 74 Understand written English. >16 Weight change, nutrition knowledge score, self-efficacy score, fat intake, health-related quality-of-life score Schnabel 2007 [] 0.070 mg/kg or 0.039 mg/kg body weight Somatropin. Max daily dosage: 3.4 mg. placebo 48 weeks, followed by an open treatment period of 24 weeks. 63 Bone age of 8-18 years, BMI 10th and/or weight 3rd percentile despite high caloric intake. Range: 9 - 20 years. Change in FEV1, height, weight, exercise tolerance. Hardin 2005 [] 1 year of GH (0.3 mg/kg per week) followed by a second year (injection) no GH for 1 year, followed by 1 year of GH 24 months 18 Received EN supplementation for≥2 years before enrollment. Range: 9 - 13 years. Pulmonary function, anthropometrics, hospitalizations, antibiotics, intake, protein turnover.
MPG_2016_02_10_DAITCH_JPGN-15-367_SDC1.docx